Literature DB >> 7904551

Refined localization of the asparagine synthetase gene (ASNS) to chromosome 7, region q21.3, and characterization of the somatic cell hybrid line 4AF/106/KO15.

H H Heng1, X M Shi, S W Scherer, I L Andrulis, L C Tsui.   

Abstract

We have mapped the asparagine synthetase gene (ASNS) to 7q21.3 by fluorescence in situ hybridization. While this study refined the localization of the gene, it also revealed a rearrangement in a somatic cell hybrid line which was used in previous ASNS mapping. Using additional probes from other regions of human chromosome 7, we showed that this cell line (4AF/106/KO15) contained a rearranged chromosome 7 in which a segment of the long arm was apparently duplicated and inserted into the short arm. Caution should be used therefore when interpreting data obtained from this cell line for gene mapping studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904551     DOI: 10.1159/000133685

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  4 in total

1.  Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency.

Authors:  Stephanie J Sacharow; Elizabeth E Dudenhausen; Carrie L Lomelino; Lance Rodan; Christelle Moufawad El Achkar; Heather E Olson; Casie A Genetti; Pankaj B Agrawal; Robert McKenna; Michael S Kilberg
Journal:  Mol Genet Metab       Date:  2017-12-20       Impact factor: 4.797

2.  Organization of heterologous DNA inserts on the mouse meiotic chromosome core.

Authors:  H H Heng; L C Tsui; P B Moens
Journal:  Chromosoma       Date:  1994-10       Impact factor: 4.316

Review 3.  Asparagine synthetase: regulation by cell stress and involvement in tumor biology.

Authors:  Mukundh N Balasubramanian; Elizabeth A Butterworth; Michael S Kilberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

Review 4.  Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia.

Authors:  Martina Chiu; Giuseppe Taurino; Massimiliano G Bianchi; Michael S Kilberg; Ovidio Bussolati
Journal:  Front Oncol       Date:  2020-01-09       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.